Navigation Links
Jury Rules in Favor of Glycoproducts International, Inc.
Date:5/28/2008

RIGGINS, Idaho, May 28 /PRNewswire/ -- Glycoproducts International, Inc., a provider of nutritional supplement products, today announced that a federal court jury sitting in the Northern District of Texas returned a mixed verdict relating to claims that Glycoproducts International, Inc. committed patent infringement of two of Mannatech, Incorporated's (Nasdaq: MTEX) patents relating to Mannatech's AMBROTOSE(R) technology.

The jury ruled in favor of Glycoproducts International, Inc., finding that they were innocent of patent infringement of Mannatech's U.S. Patent No. 6,929,807, the parent patent upon which the lawsuit against Glycoproducts International, Inc. was originally based. However, in regard to Mannatech's continuation patent of the parent patent, U.S. Patent No. 7,157,431, which was issued and first claimed to be infringed by Mannatech after the lawsuit was filed, the jury found that Glycoproducts International, Inc. had committed patent infringement.

The jury ruled in favor of Mannatech on its claims of infringement of the AMBROTOSE(R) trademark. Since Glycoproducts International, Inc. successfully defended its position against Mannatech's '807' parent patent, it will oppose Mannatech's request for an injunction to prohibit Glycoproducts International, Inc. from further production, distribution and sale of its Glycomannan(R) product.

Phil Moulton, president of Glycoproducts International, Inc. said, "Our product is distinctly different from Mannatech's products, and is a source of at least 10 of the 11 scientifically recognized biologically vital sugars, with minerals, bioflavonoids and other nutrients that naturally occur within the whole-food matrix."

"Our products are derived from natural sources and are not diluted with rice fillers," he stated.

The verdict was delivered on Friday, May 9, 2008, in the United States District Court for the Northern District of Texas, Dallas Division, following testimony before Federal Magistrate Jeff Kaplan. Glycoproducts International, Inc. (formerly Glycobiotics International, Inc.) was represented by Attorney William G. Shaw, Jr., of Collins, Basinger & Pullman, P.C.


'/>"/>
SOURCE Glycoproducts International, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Consumer Watchdog Raises Concern That Health Policy Cancellation Rules Have Been Derailed in Deal With Kaiser
2. Oregon Supreme Court Rules in Favor of R.J. Reynolds Tobacco Company in Medical Monitoring Suit
3. Virginia Judge Rules Medical Device Pioneer Committed Malpractice
4. DARA Announces Information in Compliance with NASDAQ Rules
5. MedApps Wins Nokia 2008 Mobile Rules! Business Plan Competition Award
6. MedCom Announces Court Rules Card Activation Technologies Patent Is Valid
7. VIDEO from Medialink and The Childrens Hospital of Philadelphia: New Research - Rules of the Road for Teens and Passengers
8. When the rules of the game are broken: Research studies sports injuries related to illegal activity
9. IHF Says Google Personal Health-Records System Gives Consumers Greater Control Over Privacy than HIPAA Rules
10. Aetna Requires CAQH Core Rules Certification for Vendors
11. CAQH Core Rules Final Component of HITSP Interoperability Standards Formally Recognized By HHS Sec. Leavitt
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/24/2017)... Boca Raton, Florida (PRWEB) , ... April 24, 2017 , ... ... natural chai teas, announced its products are now available for purchase on RevNutrition.com, a ... ancient form of tea first produced and popularized in ancient India and Siam. It ...
(Date:4/24/2017)... , ... April 24, 2017 , ... ... healthcare compliance and credentialing solutions, today announced that Kyle Allain has joined the ... Cactus Provider Management sales and operations, including provider, payor and managed care solutions. ...
(Date:4/24/2017)... ... April 24, 2017 , ... ... to be diagnosed globally; approximately 25,000 of them will be malignant.(1) As research ... of this type of healthcare model in the diagnosis and treatment of brain ...
(Date:4/24/2017)... IL (PRWEB) , ... April 24, 2017 , ... Rod ... the Senior Housing News website. , Rod has been at the forefront of Gardant ... company’s culture. As CEO, Rod has overseen the opening of more than 40 new ...
(Date:4/24/2017)... ... April 24, 2017 , ... As a former supermodel known for ... The good news for single women is that she put all the words in ... April 25th. Joan's insight, personal experiences and sparkling sense of humor have inspired her ...
Breaking Medicine News(10 mins):
(Date:4/20/2017)... April 20, 2017  Cogentix Medical, Inc. (NASDAQ: ... providing the Urology, Uro/Gyn and Gynecology markets with ... Keswani has joined the Company as Senior Vice ... created position, Mr. Keswani will report directly to ... "Our organization is delighted that Ash has ...
(Date:4/20/2017)... 20, 2017  RXi Pharmaceuticals Corporation (NASDAQ: RXII), ... address significant unmet medical needs, today announced that ... consumer product development program, based on its proprietary ... Investigative Dermatology (SID) 76 th Annual Meeting.  ... the sciences relevant to skin health and disease ...
(Date:4/20/2017)... -- AbbVie (NYSE: ABBV), a global biopharmaceutical company, today ... C virus (HCV) infected patients with genotype 1, ... (Child-Pugh A) achieved sustained virologic response at 12 ... pan-genotypic regimen of glecaprevir/pibrentasvir (G/P). These high SVR ... of G/P treatment without ribavirin. Patients with specific ...
Breaking Medicine Technology: